FDA Drug Approval, N022211, ZIRGAN
FDA Drug Approval, N022211, ZIRGAN
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 022211
Company: BAUSCH AND LOMB
Drug Name: ZIRGAN
Active Ingredients: GANCICLOVIR
Strength: 0.15%
Dosage Form/Route: GEL;OPHTHALMIC
Action Date: 09/15/2009
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Company: BAUSCH AND LOMB
Drug Name: ZIRGAN
Active Ingredients: GANCICLOVIR
Strength: 0.15%
Dosage Form/Route: GEL;OPHTHALMIC
Action Date: 09/15/2009
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details